Chapter 11 in Hong Kong ? What Would They Do With Mass Tort Claims ?

Here is an AmLaw article about the apparently fairly real possibility of chapter 11 type legislation in Hong Kong. This is getting ahead of the game, but it does provide an opportunity to pause and think about what Hong Kong or other sovereigns might use as an approach to corporate failures caused by mass tort claims. After all, we've seen some serious mass tort issues arise from Hong Kong's nearby neighbors.

Let's hope other sovereigns do better than section 524(g) of teh US bankruptcy code. Otherwise, we may see a global spread of mass claiming by the least sick.

Sealing a Punitive Damages Verdict for Plaintiff When Multiple Trials Are Ongoing in One Court

Here is an interesting post from the Mass Torts Profs Blog on Judge Moss in Philadelphia granting a defense motion to seal a punitive damages verdict for plaintiffs that was entered in one Prempro trial. The defense argument was that the punitive damages verdict for the plaintiff might bias the jury in an ongoing Prempro trial in the same court.

Antitrust Claims in China

Here is brief AmLaw article regarding assertion in China of a few consumer antitrust claims, and one very modest settlement.

Tags:

Cancer - - More Must Be Done - - Stark Reminders of the Human Toll

90,000 people per year travel to Houston's MD Anderson Cancer Center for treatment. Many are children. Most will not find a cure. Some will obtain more time. Almost all will suffer to achieve those additional years or months. Some will be in agonizing treatments for many months or even years. Forty years after President Nixon acknowledged the need for the so-called war on cancer, the therapies are still barbaric. Indeed, too many treatments are still so barbaric that more people than you would know will some day die from the treatments instead of the original cancer.

The staggering 90,000 number and other harsh realities are part of Gina Kolata's latest NYT article on why changes are needed in the race to prevent, manage and cure cancers. Her latest story focuses on MD Anderson to starkly highlight part of why our nation needs health care reform in general, and why our nation needs to exponentially accelerate and improve the manner in which individuals are treated for the myriad forms of cancers. Here is the image of yesterday's powerful front page picture and story. Here is the story itself.




Much more can and should be done, now. Happily, there is some expanded support triggered by the Obama Administration's support for science as detailed here. For example, the NIH and NCI are accelerating great new programs, including the Cancer Genome Atlas with wide-spread "cloud" access to the incredible amounts of new genomic information. But, much more can and should be done. Myriad cancers are starting to surrender their secrets to the brilliant doctors, new machines, and staggeringly fast computers and software that are sequencing genes and visualizing molecules at an unprecedented pace and in ways never before accomplished. Please, stay focused on the debates over health care and demand that our nation act to devote far more resources to saving more of our nation's 500,000 annual US victims and to prevent future cancers.

Can more be done in an effective way. Absolutely !

Who says so? For one, Dr. James Watson (of the Nobel prize team regarding DNA) in this powerful 2009 NYT editorial article. In just a few paragraphs, he outlines where we've been, where we are now, and why now is the time to accelerate and move forward in new ways.

For another, this 2008 book by Dr. Guy Faguet, an experienced doctor/scientist, has much to say on the subject of what's ahead and what needs to change on cancer research and treatment. http://www.amazon.com/War-Cancer-anatomy-failure-blueprint/dp/1402036183.

Dr. Faguet makes three main points. First, the "cell kill" approach to cancer is in large measure a failure. He also explains how and why the cell kill clinical trial is so slow and so tied to outmoded reimbursement systems and short-term profit models. Second, cancer prevention deserves far more effort and attention. For example, many oncogenic chromosome changes are caused by retroviruses, and so preventive vaccines are key to prevention and warrant far more effort and money. Some remarkable reductions in cancer appear to been achieved in some nations through vaccinations to eliminate one hepatitis virus. Third, the fast arriving future is finding cancer early and applying human and workable genomic therapy instead of trying to kill cancer cells after they are widespread.

Can this be done, politically speaking ? Yes. For that subject, see Dr. Harold Varmus' book - The Art and Politics of Science.

Dr. Varmus credentials ? Nobel Prize winner as part of a team of cancer researchers, head of the NIH for the Clinton Administration, and now the leader of Memorial Sloan Kettering. http://www.amazon.com/Art-Politics-Science-Harold-Varmus/dp/0393061280/ref=sr_1_1?ie=UTF8&s=books&qid=1256563341&sr=1-1

New Opinion in Australia on Registrations for Litigation Funding and Class Actions

Courtesy of Mondaq and Google, I encountered this article from AU law firm Middelton's regarding a new appellate opinion in Australia on litigation funding. The appellate court opinion arises in the context of funding for a class action. The Middelton's article kindly included a link to the opinion, which is here. The upshot seems to be that there are more required registrations than had been perceived for litigation funding in Australia for class actions.

The entire article and opinion need to be viewed. But, here's the short summary from the article:

"Consequences

There are numerous shareholder or investor class actions currently before the courts or that are anticipated and many of those are backed by litigation funding on terms similar to those present in this case. The Full Court's decision means that those class actions should probably have been registered as Managed Investment Schemes.

Running a Managed Investment Scheme entails a wide range of commercial, legal and compliance issues, including the requirement to hold an Australian Financial Services Licence (AFSL). Whilst such issues are not insurmountable for the litigation funder, obtaining the AFSL and registration of the scheme is a complex process that ordinarily takes many months. Where the litigation funder is a foreign entity (as is the case with ILF), that process is likely to be further complicated.

In the Brookfield Multiplex case, the Full Court stated that the defendant in a representative proceeding is entitled to have confidence in its dealings with the solicitors, for the claimants that they are properly authorized to act, and that the proceedings will not, in the future, be disrupted or delayed by any intervention by ASIC or a disgruntled group member, asserting an irregularity of the nature identified here. Those comments call into question the status of other class actions currently before the courts and may present an obstacle for claims in contemplation unless suitable arrangements are put in place.

The other consequence of the judgment may be that litigation funders and solicitors running representative proceedings shy away from class actions that involve retail investors (ie the "mums and dads" of the investment community) as an investment scheme involving large or institutional investors will not require registration (but the manager of that scheme will still need an AFSL).

To view the citation to the judgment please click here.

Travelers/Manville Remand - 2d Circuit Argument is Thursday October 22 at 2:00 PM

The Supreme Court's Manville/Travelers opinion was quite narrow (some might say advisory) and resulted in a remand of the case to the 2d Circuit to decide the extent to which the prior rulings are binding on various entities. As per this online docket, the Travelers/Manville argument on remand is set for oral argument today. at 2:00 pm at the 2d Circuit. Assuming I'm reading the schedule correctly, the appellate panel will consist of Judges Calabresi and Wesley, and also will include the now fairly famous Judge Rakoff sitting on the panel by designation. Go here to see the panels.


UPDATE on the UPDATE: Pleural Plaques in the UK - The Dance Goes On

Update on the Update: Through the written question and answer process, the UK government issued an October 21 acknowledgment here that it does not have a date in mind to announce a decision on pleural plaques, but the response will be made "as soon as possible."

"Julia Goldsworthy (Falmouth & Camborne, Liberal Democrat)

To ask the Secretary of State for Justice when he expects to announce his decision on compensation for those with pleural plaques; and if he will make a statement.

Bridget Prentice (Parliamentary Under-Secretary, Ministry of Justice; Lewisham East, Labour)

The House of Lords decision has raised extremely complex and difficult issues which have required very careful consideration within Government. It has also been important to look beyond the issue of pleural plaques itself to consider how people who have been exposed to asbestos can be supported much more widely. We are actively considering all these issues in order to be in a position to publish a final response as soon as possible."

Update: Go here for the full text of debates in official form or here for the same text arranged by speaker and topic on TheyWork forYou.


The pleural plaques dance/debate continued yesterday in the UK House of Commons. The latest move is an apparently futile bill seeking to reinstate the ability to make claims for pleural plaques. Here is the link to a media story. The House of Commons comments should be online in a day or two. The Brown Administration still has not taken a firm position.

Here is the prior post that includes a paper I submitted to argue why it would be a grave mistake to reinstate plaques claiming.

"Asbestos-related illness decision may be overturned

7:59am Saturday 17th October 2009

By Rob Merrick »

VICTIMS of an asbestos-related illness were given fresh hope of compensation yesterday.
A Bill to overturn a Law Lords ruling denying payouts to sufferers from pleural plaques - a scarring of the lungs, that can trigger mesothelioma and lung cancer - cleared the Commons.
But ministers made it clear they stood ready to block the Damages (Asbestos-Related Conditions) Bill in the House of Lords, if necessary.

They have argued that only five per cent of pleural plaques sufferers develop asbestos-related diseases and that changing the law would open the floodgates to other compensation claims worth billions.

It is 15 months since the Government signalled it would not overturn the 2007 ruling, however, it has not confirmed the decision after Labour MPs reacted with outrage.

Yesterday, Justice Minister Bridget Prentice apologised to MPs after admitting a final decision was no closer, adding: "That is very frustrating for everyone concerned."

As a result, ministers had little choice but to allow the backbench Bill to pass to the Lords. It was given a third reading by 51 votes to zero.

But the Bill has less than four weeks to clear the Lords and Ms Prentice admitted that ministers would step in to prevent it reaching the statute book if necessary.

Under the Government's proposals, only the existing 6,500 pleural plaques sufferers would receive "no fault" payouts of up to £5,000, funded by the taxpayer, rather than insurance companies.
Future victims would receive no damages until a serious disease developed, by which time an employer or insurance company may have disappeared, making it harder to prove liability."

Delaware Catholic Diocese to Use Chapter 11 to Manage Tort Cases Regarding Priests

Law360 and various news services had articles over the last two days regarding the Delaware Catholic Diocese filing for chapter 11 due to pending tort claims arising from priests molesting children. The Diocese is represented by Wilmington's Young Conaway law firm, which has been involved in many of the asbestos chapter 11 cases as counsel for futures reps. Will we see a trust fund or just tort claim resolution ? Either way, this presents just the latest example of how chapter 11 is being used as just another to to resolve tort claims. Here are two key quotes from the Law360 article.


"Filing for Chapter 11 offers the best opportunity, given finite resources, to provide the fairest possible treatment of all victims of sexual abuse by priests of our diocese," Bishop W. Francis Malooly of the Wilmington diocese said in a statement.

"Our hope is that Chapter 11 proceedings will enable us to fairly compensate all victims through a single process established by the bankruptcy court," Malooly said.

Structured Settlements versus Lump Sum Settlements - What are the Facts ?

Thanks to the Empirical Legal Studies blog post here, here is the link for a student paper asserting that there no facts to back up the practice of promoting structured settlements instead of lump sum settlements.

Great New Science - Diagnosing a Disease Based on Gene Sequencing - in 10 Days

Here's a science follow up to yesterday's historic ruling by the Massachusetts Supreme Court regarding medical monitoring due to genome level changes. Yesterday, a story popped up that illustrates how fast and far medicine and genomics are moving thanks to incredible computer speeds and software. The gist? In 10 days, scientists sequenced an entire human genome and diagnosed a disease that had baffled the clinicians !!

The full story is here, from the Howard Hughes Medical Institute. Here are key excerpts:

"October 19, 2009 Diagnosis Emerges from Complete Sequencing of Patient's Genes

For the first time, scientists have diagnosed a genetic disease by completely sequencing all of a patient's genes. Using high-throughput DNA sequencing technology, Howard Hughes Medical Institute (HHMI) researchers successfully identified a gene mutation that was responsible for the patient's disease, but had not been suspected based on clinical observations.

Starting with DNA from a blood sample from the patient -- an infant in Turkey who was persistently dehydrated and failing to gain weight - the team found in 10 days a gene mutation known to affect electrolyte transport in the intestines and cause a condition called congenital chloride diarrhea. Doctors in Turkey confirmed the diagnosis clinically and were able to provide a treatment tailored to the disease.

***

I think in the coming years we're going see a dramatic increase in the use of this kind of technology," Lifton says. "This is going to be a very powerful technology for disease-gene discovery and clinical application." Lifton and his colleagues reported their method and diagnosis in an advanced online publication of the Proceedings of the National Academy of Sciences on October 19, 2009."

Tags:

Massachusetts High Court Ruling Approves a New Medical Monitoring Claim Involving Smokers, Low Dose CT Scans and Cellular Changes

Today was not a good day for the tobacco industry or certain other "mass tort" defendants and/or insurer involved with cancer claiming. Why? Despite opposition briefs from almost every major defense group in the US (see n.4), the Massachusetts Supreme Court today issued a unanimous opinion approving a tort claim to obtain medical monitoring using low dose CT scans to seek to find lung cancer very early for a class of people at meaningful risk of cancer due to many pack years of prior or current smoking of Marlboro cigarettes. See below for the elements of the claim.

The opinion also is noteworthy for two other reasons. First, it includes a ruling on when and how a defendant can win a statute of limitations defense. It will not be easy for the defense since the opinion to a large degree suggests a focus on what a physician has told the plaintiff. The opinion also includes a ruling to protect plaintiffs against splitting a cause of action. The latter ruling is that if cancer does manifest itself, the plaintiff can bring a new claim even if he or she already made a claim for medical monitoring.

The opinion is available online here from the Court, and also is available on Westlaw. It is Donovan v. Philip Morris USA, Inc., --- N.E.2d ----, 2009 WL 3321445 (Mass.)

Go here for my prior post predicting this type of outcome and providing data and facts on cancer that help to explain why this ruling will, over time, become quite important. Go here for NAM's opposition brief.

The elements of the approved medical monitoring claim are:

"In conclusion, each plaintiff must prove the following:

(1) The defendant's negligence (2) caused (3) the plaintiff to become exposed to a hazardous substance that produced, at least, subcellular changes that substantially increased the risk of serious disease, illness, or injury (4) for which an effective medical test for reliable early detection exists, (5) and early detection, combined with prompt and effective treatment, will significantly decrease the risk of death or the severity of the disease, illness or injury, and (6) such diagnostic medical examinations are reasonably (and periodically) necessary, conformably with the standard of care, and (7) the present value of the reasonable cost of such tests and care, as of the date of the filing of the complaint."

Here are key excerpts from the opinion as to the Court's rationale:

"Modern living has exposed people to a variety of toxic substances. Illness and disease from exposure to these substances are often latent, not manifesting themselves for years or even decades after the exposure. Some people so exposed may never develop an illness or disease, but some will. Subcellular or other physiological changes may occur which, in themselves, are not symptoms of any illness or disease, but are warning signs to a trained physician that the patient has developed a condition that indicates a substantial increase in risk of contracting a serious illness or disease and thus the patient will require periodic monitoring. Not all cases will involve physiological change manifesting a known illness, but such cases should be allowed to proceed when a plaintiff's reasonable medical expenses have increased (or are likely to increase, in the exercise of due care) as a result of these physiological changes. We leave for another day consideration of cases that involve exposure to levels of chemicals or radiation known to cause cancer, for which immediate medical monitoring may be medically necessary although no symptoms or subclinical changes have occurred. Here, the physiological changes with the attendant substantial increase in risk of cancer, and the medical necessity of monitoring with its attendant cost, may adequately establish the elements of injury and damages.

Our tort law developed in the late Nineteenth and early Twentieth centuries, when the vast majority of tortious injuries were caused by blunt trauma and mechanical forces. We must adapt to the growing recognition that exposure to toxic substances and radiation may cause substantial injury which should be compensable even if the full effects are not immediately apparent. See Hansen v. Mountain Fuel Supply Co., 858 P.2d 970, 977 (Utah 1993). When competent medical testimony establishes that medical monitoring is necessary to detect the potential onset of a serious illness or disease due to physiological changes indicating a substantial increase in risk of harm from exposure to a known hazardous substance, the element of injury and damage will have been satisfied and the cost of that monitoring is recoverable in tort. No particular level or quantification of increase in risk of harm is necessary, so long as it is substantial and so long as there has been at least a corresponding subcellular change. Id. at 979-980. This should address any concern over false claims, see Payton v. Abbott Labs, supra at 552-555, yet permit a genuinely injured person to recover legitimate expenses without having to overcome insurmountable problems of proof in this difficult and complex area. In this respect, medical expenses are recoverable not only for direct treatment and diagnosis of a present injury or an injury likely to occur, but for diagnostic tests needed to monitor medically a person who has been substantially exposed to a toxic substance that has created physiological changes indicating a substantial increase in risk that the person will contract a serious illness or disease. The expense of medical monitoring is thus a form of future medical expense and should be treated as such."

Report on Civil Justice in Scotland Calls for Class Actions and More Work on Litigation Funding and Contingency Fees

Lord Gill's report on civil justice in Scotland was issued on 30 September. The full report and the synopsis are available here. See below for some key excerpts from the synopsis.


"Multi‐party actions (Chapter 13)

The Report recommends that there should be a special procedure for dealing with multiple claims which give rise to common or similar issues of fact or law, for example, litigation arising out of a mass disaster or liability for defective products. Detailed recommendations are made regarding the features that such a procedure would have, including special funding arrangements for multi‐party actions to be administered by the Scottish Legal Aid Board (see paragraphs 64‐119).

The cost and funding of litigation (Chapter 14)
Detailed recommendations are made on the recovery of expenses. The cost of litigation should form part of the remit of the proposed Civil Justice Council for Scotland (see below); pending which the Scottish Government should set up a Working Group to look at the issue of expenses (paragraphs 50‐67).

While no recommendations are made on speculative fee arrangements pending the outcome of a review in England and Wales, it is recommended that this issue should urgently be addressed by the proposed Working Group on Judicial Expenses (see paragraphs 125‐127).

The Scottish Government should explore with insurance providers the scope for improving public awareness and increasing voluntary uptake of legal expenses insurance (see paragraph 140)."

More on Apologies. a Topic Related to Medical Malpractice and Other Tort Claim Situations

This entry from Conglomerate caused me to see this article in Business Week on the power of apologies. This research is consistent with information suggesting that medical malpractice claims are best resolved by admitting errors, making a payment and moving forward, as described in a short NYT article covered by my prior post here. For a scholarly and persuasive article on the University of Michigan's favorable experience with apologies for medical malpractice, go here.




________________________________________________________________




Why It Pays to Apologize
What's the best way for a company to disarm a disgruntled customer? A simple apology beats a cash rebate, according to a new study.
Researchers at Britain's Nottingham School of Economics worked with a large German wholesaler that sells goods on eBay (EBAY), tracking the lukewarm or negative comments posted on the site by the company's customers over six months.
They then responded to the 632 complaints--about defective salt shakers, say, or the late delivery of a leather belt. Half of the e-mailed responses offered a brief apology. Half offered instead a "goodwill gesture" of a small cash rebate (from $3 to $8). All the e-mails asked the customers to remove the comments they had posted online. For those offered the rebate, it was a condition of receiving the cash.
The result? About 45% of customers who received an apology withdrew their so-so or negative ratings, compared with 21% of those offered money to do so.
Johannes Abeler, a Nottingham research fellow and co-author of the study, says it's worth noting that the e-mailed apologies were effective even though they were brief and impersonal--and asked for something in return. His explanation? Despite the suspicions people might harbor, "apologies trigger this biological instinct to forgive that is hard to overcome."
--Douglas MacMillan

Burford Fund Goes Public in Britain - $ 130 Million Raised for Litigation Funding

Regardless of what some may think, investors apparently like the idea of litigation as an investment vehicle. The proof ? Burford Capital this week succeeded in raising $ 130 million in its IPO.

Here is an Am Law article by Alison Frankel in which she declares: "It's time to declare litigation financing a bona fide investment class."

Here is the link to a Bloomberg story on Burford's IPO.

Britain Celebrates Implementation of its Supreme Court

I learned a couple of weeks ago that Britain would soon be implementing a Supreme Court instead of the House of Lords. Here is a new AP article on the formal ceremony.

An interesting additional point to the article is that some members of our Supreme Court went over for the ceremony (and Justice Ginsberg tried to go over). One wonders if this means they are now more willing to listen to and consider the rulings made by the courts of other nations.


Queen Elizabeth II Opens New U.K. Supreme Court

The Associated Press

October 16, 2009


Queen Elizabeth II formally opened Britain's new Supreme Court on Friday in a ceremony attended by high court justices from the United States and around the world.

Prime Minister Gordon Brown and top judges from Canada, Australia, India, South Africa and Europe attended the ceremony for a court the government says will make the workings of justice visible and accessible to the British public.

U.S. Chief Justice John Roberts and justices Stephen Breyer and Antonin Scalia watched the ceremony, which included prayers led by Archbishop of Canterbury Rowan Williams and a verse for the new court by former poet laureate Andrew Motion.

U.S. justice Ruth Bader Ginsburg also had been scheduled to attend, but she became ill just before her plane took off from Washington late Wednesday and was briefly hospitalized. U.S. court officials said Ginsburg, 76, became drowsy because of a reaction to medicine.

For hundreds of years, Britain's highest court of appeal was the Law Lords, a group of justices who sat in Parliament's upper chamber, the House of Lords.

Earlier this month the judges shed their wigs and ermine-trimmed robes and moved to a new home in a renovated 100-year-old courthouse across Parliament Square from the Houses of Parliament. The court began hearing cases Oct. 5.

The government says the new court corrects one of the quirks of Britain's ancient and unwritten constitution, separating the country's judicial and legislative powers after hundreds of years of muddled compromise.

Brown said that, with the formation of the court, "a separation of powers once only guaranteed by convention is now cemented by statute."

The new court also is equipped with cameras and microphones so proceedings can be broadcast. Recording is prohibited in most British courts.

Justice Secretary Jack Straw said Friday that the Supreme Court underlined the independence of the judicial system. He said the work of the Law Lords had been "opaque and was obscured from public view." "In this place we now have this court -- public, accessible, visible -- situated in this square at the heart of our nation's history over a millennium," Straw said.

Galleon Hedge Fund - Insider Trading Ring

Here are the insider trading charges against Galleon's founder and here is an NYT article on the scam. The insider trading ring is described as follows;

" As outlined by law enforcement officials, Mr. Rajaratnam tapped a vast network of informants across a swath of corporate America: a senior official at I.B.M. considered a contender for the top job at that firm; executives of Intel and the consulting firm McKinsey & Company; two former Bear Stearns employees who had moved to a hedge fund, New Castle Partners; and an analyst at Moody's Investors Service.

While trading secrets, though, one crucial piece of information was not shared -- the phones were tapped. The wiretaps, said by prosecutors to be the first in an insider-trading case, were made with the assistance of an unnamed cooperating witness, a former Galleon employee who was said to ply Mr. Rajaratnam with information originally to land a job."

Tags:

"Legal Reform Summit" - Views of the US Chamber of Commerce and Academics On Litigation Funding and Other Tort Related Topics

So, what do academics and the US Chamber of Commerce think about litigation funding? I'm not sure, but if you want to know, then plan to attend an October 28 seminar in DC. The front page for the seminar is pasted below, in pertinent part. Here is the link for online registration.

Note also that there are various other tort topics, including the last panel - predicting the agenda for the plaintiff's bar.

___________________________________________________________________

OCTOBER 28, 2009 - U.S. CHAMBER OF COMMERCE -- WASHINGTON, DC

Please join the U.S. Chamber Institute for Legal Reform for our 10th Annual Legal Reform Summit on Wednesday, October 28, 2009, featuring:

Legislative Keynote Morning Address
by U.S. Senator Jeff Sessions, Ranking Member of the U.S. Senate Judiciary Committee

and

"Leading in a Climate of Change"Keynote Luncheon Address
by Jeb Bush, former governor of Florida.

In addition, Tom Donohue, President and CEO, U.S. Chamber of Commerce, will provide special remarks. The Summit will also feature distinguished panelists exploring a variety of timely legal topics, including:


Courting New Money: Third Party Financing of Litigation and its Consequences. Should Outside Investors Have a Stake? Academics will release new research and discuss and debate the growing trend of third parties financing lawsuits.

Climate Change Litigation: The New Mass Tort for the 21st Century? Panelists will speak to the legal theories and trends in climate change litigation as well as regulatory and legislative developments and their impact on the business community.
Judicial Selection: Best Practices in Nomination States. ILR will release a "best practices" guide to judicial selection in nomination states.

It's Economics Stupid: Exploring the Relationship Between Lawsuits and Rising Healthcare Costs. Jeb Bush will facilitate a panel discussion on the economic impact of lawsuits on the practice of medicine and rising healthcare costs.

Trial Lawyer Crystal Ball: Predictions and Prognostications on the Road Ahead. We will host a discussion on the trial bar's priorities.

Tort Wars - The Next Step in the Toyota Saga Regarding Alleged Document Destruction

Here is a different example of how mass tort litigation ends up becoming a media story. In this instance, the media consists of the latest story on Toyota's battles regarding alleged destruction of internal documents in order to avoid the information becoming evidence in rollover cases.

The short version is that after suing Toyota for wrongful discharge, a former inside lawyer has turned over to a federal judge four boxes of documents that are said to support his claim that documents were wrongfully destroyed by Toyota. The judge has ordered the documents to be secured, scanned and coded, and will give Toyota a chance to claim privilege regarding the documents. No doubt plaintiff's lawyers will then assert the crime-fraud exception applies to any otherwise privileged documents. The judge's ruling presumably will be widely reported.

How would you like to be the General Counsel dealing with this situation ? What would you want to know and then what would you decide to do when no one will give you the answers you need ? Much wisdom on the subject of crisis management has been spelled out before by business consultants. See, e.g,, Stop The Presses: The Crisis and Litigation PR Desk Reference. Written by Richard Levick and Larry Smith of Levick Strategic Communications, the book addresses crisis management in general, and its chapters 7 and 8 deal with strategies for dealing with blog stories and other issues that were more or less immaterial as little as 5 years ago. Also potentially relevant is its chapter 9 on the impacts of media related to prosecutorial activity.


Mass Torts, Media, and the Dole Chemical Exposure Cases

Here is a story regarding yet another aspect of the "mass tort" litigation industry - movies and other media drivers of public opinion. Remember - this situation is not unique. Indeed, other movies about "mass torts" were far bigger, such as Erin Brokovich and A Civil Action. Today, the mass tort wars are fought on many fronts and there are many forums for the battle over public opinion and perception, all of which can effect corporate reputation and the corporate stock price.

Recall also that there are two sides two every story, and that Dole's actions were portrayed as less than laudable in this August 19, 2009 Wall Street Journal article by Steve Stecklow. Set out below are 1) the AP article and 2) key excerpts from the WSJ article.

________________________________________________________________

Dole withdraws lawsuit against Swedish filmmaker

By MALIN RISING (AP) - 4 hours ago

STOCKHOLM -- Dole Foods is withdrawing a defamation lawsuit against a Swedish filmmaker after complaints in Sweden that it was trying to limit free speech, the company said Thursday.
Dole had sued filmmaker Fredrik Gertten for showing his controversial documentary "Bananas!" despite a court ruling that said it was based on a fraud.
The move sparked protests in Sweden, critics said the food company was trying to interfere with the freedom of speech.
In a statement, Dole said it decided to withdraw the lawsuit "in light of the free speech concerns being expressed in Sweden, although it continues to believe in the merits of its case."
"While the filmmakers continue to show a film that is fundamentally flawed and contains many false statements we look forward to an open discussion with the filmmakers regarding the content of the film," Dole's Executive Vice President and General Counsel, C. Michael Carter said.

The documentary shows the alleged plight of Nicaraguan workers who say they were made sterile by a pesticide used at Dole banana plantations in the 1970s. It was completed before a fraud was uncovered showing that the workers were recruited by a lawyer to lie. That ruling has been appealed.

Earlier this week Swedish food chain ICA -- a Dole customer -- held a meeting with the company saying it felt the filmmaker had the right to express his side of the story.
"We met their European division and ... put forward our view on the matter," ICA's fruit and vegetables chief Lars Astrom told The Associated Press. "We said we thought they should withdraw the lawsuit and asked them to get back to us, and now they have done that."
The film's producer, Margarete Jangard, welcomed Dole's decision.
"It feels fantastic that we have been able to make a difference, without an
y money, only with the help of all the people who have supported us," she told the AP.

The film was shown twice in June with a lengthy written disclaimer by Los Angeles Film Festival organizers who said it did not present a fair and accurate account but was worth showing as "a case study" of what happens when a story changes after a documentary is completed.
Copyright © 2009 The Associated Press. All rights reserved.


______________________________________________________________
Excerpts from WSJ:

" DBCP, short for dibromochloropropane, was widely used around the world in the 1960s and 1970s to control microscopic worms called nematodes that attack roots and destroy crops. "The first year after we used" the pesticide, "the bananas were huge," says Isaias Paz, who worked for years as a foreman on a Dole-operated banana plantation outside Chinandega.
In 1977, California health officials discovered that workers at a DBCP manufacturing plant there had become sterile. Another manufacturer, Dow Chemical Co., one of Dole's suppliers for Central America, stopped production and announced a recall.
Dole, which began using the pesticide in Nicaragua in 1973, had a contract to purchase DBCP for another two years. It threatened Dow with breach of contract for stopping deliveries, stating there was no evidence that plantation workers who apply DBCP had been rendered sterile, according to records in a lawsuit later filed by Dow against a Dole unit in Michigan circuit court. In 1978, Dow agreed to sell Dole some of its remaining stocks only after the fruit company agreed to hold Dow harmless from any injury claims.
In 1979, the U.S. Environmental Protection Agency banned DBCP in the U.S. for nearly all uses, including bananas, stating that "farm workers, pesticide applicators and the public at large...run varying degrees of risk of cancer, gene and chromosomal damage" and male infertility. Dole stopped using the pesticide in Nicaragua in 1980, according to Scott A. Edelman, a Dole attorney. The company's "use of the remaining stocks" of DBCP from 1978 to 1980 "was legal," he says."

SEC Sued by Investor for Failing to Stop Mr. Madoff's Scheme

Here is a link to an American Lawyer article detailing a defrauded investor's suit against the SEC for failing to uncover and stop Mr. Madoff's fraud. According to the article, plaintiff's counsel is a former SEC lawyer who acknowledges sovereign immunity rules but has tried to plead around them. The claims are asserted under the Federal Tort Claims Act.

Canadian Court Allows Indirect Purchaser Antitrust Class Action

Here is an interesting paper from Davies Ward Phillips & Vineberg on a Canadian trial court decision certifying an antitrust class action for indirect purchasers of hydrogen peroxide products. The commentators view the decision as a potentially significant expansion of Canadian law if the decision withstands appeals. A key excerpt is as follows:


"In Irving Paper, Justice Rady relied on two more recent decisions of the Ontario Court of
Appeal - Markson v. MBNA Canada Bank and Cassano v. The Toronto Dominion Bank - to
frame her analysis of the issue. In her view, these two decisions have overtaken Chadha
and signal a relaxation of the evidentiary threshold prescribed by Chadha. Among other
things, Her Honour interpreted Markson as establishing "that not every class member need
have suffered a loss and so it is not necessary to show damages on a class-wide basis".
Justice Rady also relied on the Ontario Superior Court's 2004 decision in Hague v. Liberty
Mutual Insurance Co. and the Ontario Court of Appeal's decision in Cloud v. Canada
(Attorney General) as authority for the proposition that she was not required to reconcile the
conflicting expert opinions before her regarding the existence of a workable class-wide
means to prove liability.

Another US Plaintiff's Firm Moves into Europe

Mark Lanier's plaintiff's firm is expanding operations into London. As described in the media, the firm is establishing an arbitration practice. Here is the firm's press release and here is a law.com article.

The press release does not say this but one can envision that this effort has larger goals than simply handling some commerical cases. Instead, one can see this move as following a model set by others. That is, branch out to a new market using a product that will pay for itself more quickly than does tort litigation. That is, business litigation for hourly and/or contingent fees usually follows a time line that is shorter than the timeline for tort litigation. At the same time, that business litigation platform provides a basis for developing local skills and contacts that will be exploitable as the market for tort litigation evolves and expands over time.

Vice Chancellor Strine's Comments on Corporate Decision Making and Risk Taking, Including Conflicts of Interest Between Constituencies

One reality of modern life is that large scale corporate actions and decisions can and do profoundly effect the financial and physical lives of innumerable people. To name but a few, consider the financial impacts of the ongoing financial fiasco and large-scale scams exemplified by Mr. Madoff, and consider the physical impacts of now-banned chemicals and asbestos. Accordingly, the subject of corporate decision-making is important to many currently ongoing policy debates that involve both national and international laws.


On the topic of corporate decision-making and regulation, I commend for thought the following words by Vice Chancellor Leo Strine, an experienced and respected Delaware Chancery judge. Note especially his comments about conflicts of interest between corporate constituencies. In that vein, consider also the Parmalat ruling discussed here last week on the in pari delicto defense and its elements.

My view? Mr. Strine's observations are correct. Unfotunately, most judges, legislators and academics do not have the benefit of Mr. Strine's experiences and and so many but not all of our legislatures, agencies and common law courts are making far less than optimal decisions because they do not understand or acknowledge the complexities and conflicts of interest present in much of modern corporate behavior and in many cases presently in litigation. One result is that efforts to legislate or regulate are increasingly ineffectual. Another result is that corporate mistakes and/or fraud are followed by explosions of litigation, and soon all sides are more or less accurately complaining that litigation is too slow and too expensive. And, some times, the lawsuits produce only woefully tiny sanctions for those who were part of or turned a blind eye to grossly illegal behavior. Moreover, because we are human and grow tired of the past, there is a lessening of the attention paid to white papers and committee reports any particular problem, and so attention turns to the next debacle.

Will societies ever break out of this cycle? I hope so, and suggest that doing so requires the arduous but necessary step of making better decisions at the start by hearing from more conflicting constituencies at earlier points in various decision-making processes.


(As a preface for those readers who may not know, Vice Chancellor Strine sits in the Delaware Chancery court that each year is the venue for a large percentage of the major corporate litigation in the US. The judges of that court each year see and resolve myriad legal issues involving corporate decision making at board room levels. The judges often decide cases based on extensive testimony from senior players in the business and m & a world, and the judges also see many of the writings of the decision-makers, some genuine and spontaneous emails and others comprised of legal word smithing designed to provide evidence to support a later defense that the actions were not illegal. These experiences offer the chancery judges some unique windows to look inside corporations to see how decisions in fact are made.)

The comments by Vice Chancellor Shrine are online here, and also are pasted in below in full text. Vice Chancellor Shrine's comments are part the NYT Dealbook pages presenting an online dialogue last week regarding the roots and causes of the financial fiasco. Most of the entries are worth reading. Hat tip to the Conglomerate blog for drawing my attention to the fact that Mr. Strine was a participant.


_________________________________________________________________


" Why Excessive Risk-Taking Is Not Unexpected
October 5, 2009, 1:30 pm



Whatever the possible causes of the recent financial debacle, it seems clear that there is one cause that can be ruled out: that the directors and managers of the failed firms were unresponsive to investor demands to take measures to raise profits and increase stock prices.

Rather, to the extent that the crisis is related to the relationship between stockholders and boards, the real concern seems to be that boards were warmly receptive to investor calls for them to pursue high returns through activities involving great risk and high leverage. Indeed, the recent financial industry debacle is perhaps most surprising for its predictability in light of mundane realities accepted by social scientists of the center left and right.
It is well known that businesses aggressively seeking profit will tend to push right up against, and too often blow right through, the rules of the game as established by positive law. The more pressure business leaders are under to deliver high returns, the greater the danger that they will violate the law and shift costs to society generally, in the form of externalities. In that circumstance, if the rules of the game themselves are too loosely drawn to protect society adequately, businesses are free to engage in behavior that is socially costly without violating any legal obligations.

Moreover, the ability of any particular firm to resist imitating the overly risky, but law-compliant behavior of competitors will be compromised to the extent that managers face criticism or even removal for not keeping up with so-called industry leaders whose high, short-term returns have pleased a stock market filled with short-term investors looking for alpha.

Similarly, when power and influence over corporate activities is exerted by those whose primary interest is immediate gain and who have little or no intention to stay invested until the full costs of risky activity are borne -- e.g., certain institutional investors who invest the money of others -- corporate managers will have an incentive to be responsive to their demands.

When the marketplace presents opportunities for corporations to generate immediate gains through transactions structured so the profits are taken up front and the risks are perceived as minimal, corporations seeking to please a short-term-focused market are likely to seize them. Risks might be sold immediately to others, or theoretically contracted away through arrangements that look like insurance but don't involve counterparties meeting the standards that apply to insurance companies. Or perhaps the risk is structured to kick in several years down the road.

Likewise, when institutional investors with strong voting clout encourage corporations to increase leverage in order to engage in stock buybacks, increase dividends or reap higher trading gains, responsive corporate boards may leave their corporations without adequate capital to weather tough times, times when many of the proponents of leverage are likely not to be around as stockholders anymore.

If an industry senses that the United States Treasury has its back in the event that risky activity threatens the industry's health, its leaders may respond even more freely to these market incentives, because they view the industry as having a form of insurance from the taxpayers. When the industry and its leaders have also designed compensation systems that reward managers for generating short-term profits through risky activity -- systems often implemented with the encouragement of investors desiring to give managers a strong incentive to pump up stock prices -- managers who might otherwise be more focused on the long-term health of their employers are encouraged to go hellbent for leather for immediate gain, too.

During the last 30 years, it is indisputable that: (1) regulatory standards have been greatly relaxed, giving the financial industry free rein to leverage itself to the hilt and to engage in a wide range of speculative and increasingly opaque, complex activities, often without rigorous safeguards; (2) the power of stockholders to influence the composition of corporate boards and the direction of corporate strategy has been markedly enhanced; (3) institutional investors who hold stocks, on average, for a very brief period of time and are highly focused on short-term movements in stock prices have become far more influential and prevalent; and (4) "pay for performance" compensation systems were implemented to align the interests of managers with stockholders by giving managers incentives to pump up corporate profits in a manner that will increase the corporation's profits and stock price immediately, rather then durably.

Distilled down, what is most critical is that robust prudential regulation protecting society from risky corporate activity abated, precisely when corporations faced increasingly strong pressures to engage in much riskier endeavors in order to generate short-term results. In the financial sector, this potent cocktail was chased by several governmental interventions to rescue the industry when its "innovative" activities threatened its health, a course of conduct that suggested that the financial industry could take risks other industries could not, because it had a de facto form of federal insurance.

There is, of course, much that is simplified about this description. But, it is in the main true. And it suggests that policy makers need to be mindful of the relationship between the power of the stock market to influence corporate policies and the strength of prudential regulation. Because even diversified long-term stockholders are likely to have an appetite for risk that exceeds what is socially prudent, there will always need to be strong rules of the game to govern industries whose failure poses socially unacceptable risks.

There is no escape from the fact that although corporations are sometimes seen as owned by those who own their equity and elect their boards, the actions of corporations affect a broader range of constituencies, including workers, creditors, consumers and society more generally; no sensible regulatory system can ignore that fact.

The difficulty is compounded when those who directly influence public corporations are not primarily end user investors focused on the long term and keenly worried about excessive risk -- think workers who must invest in mutual funds for retirement -- but far more likely to be financial intermediaries whose investment horizons are often less than a year.

Strong regulatory standards are indispensable, not simply for society, but also for end-user long-term investors themselves, who bear the long-term costs of corporate idiocy.

Therefore, if the correct policy balance is to be struck regarding regulation of the financial industry and other industries that pose large systemic and societal externality risks, policy makers cannot continue to avoid the obvious alignment problem that now vexes our corporate governance system.

Most Americans invest with a rational time horizon consistent with sound corporate planning. They invest with the hope of putting a child through college or providing for themselves in retirement. But individual Americans don't wield control over who sits on the boards of public companies. The financial intermediaries who invest their capital do. These intermediaries have powerful incentives -- in important instances, not of their own making -- to push corporate boards to engage in risky activities that may be adverse to the interest of long-term investors and society. That is, there is now a separation of "ownership from ownership" that creates conflicts of its own that are analogous to those of the paradigmatic, but increasingly outdated, Berle-Means model for separation of ownership from control.

Unless these incentives and conflicts are addressed, it should be expected that corporate boards will continue to face strong pressures to manage their enterprises in a manner that emphasizes the short term over the long term, and that involves greater risk than is socially optimal. As a result, more stringent than optimal prudential regulation will have to be in place to bar the financial sector from taking risks that endanger society as a whole, rather than simply the capital of their investors and the employment of their employees.

There is nothing new about the insight that the more incentives businesses have to generate short-term profits, the more likely it is that they will engage in excessively risky activity, especially if they believe that the risks will be borne by others if they come to fruition. We simply have another hard-learned lesson to point to about the costs of ignoring these realities.

In shaping the future, policy makers might therefore focus on two key objectives: re-instituting sound prudential regulation over financial institutions critical to the overall well-being of our capital markets and economy, and implementing policies that focus stockholders and boards on the objective of having corporations produce wealth in both sound, durable fashion.

Ideally, we want a system where corporate boards are highly accountable and responsive to their stockholders for the generation of sustainable profits. But for that policy objective to be achieved, stockholders themselves must act like genuine investors, who are interested in the creation and preservation of long-term wealth, not short-term movements in stock prices. So long as many of the most influential and active investors continue to think short term, it is unrealistic to expect the corporate boards they elect to strike the proper balance between the pursuit of profits through risky endeavors and the prudent preservation of value.

Leo E. Strine Jr., vice chancellor of the Delaware Court of Chancery, is also the Austin Wakeman lecturer in law of Harvard Law School, an adjunct professor of law at the University of Pennsylvania and Vanderbilt law schools, and a Crown Fellow with the Aspen Institute."

Proposal for National Juries for Mass Tort Cases

Here is a late September post presenting a condensed version of a law review article proposing "national juries" for mass tort litigation. The proposal is from Professor Laura Gaston Dooley, a professor at the Valparaiso University Law School. Looking quickly through her CV at the school website, it appears Prof. Dooley clerked for two years for federal judges and then joined academia. Her work also includes being a part of the "Members Consultative Group, Project on Aggregate Litigation. American Law Institute," which is a group identified here.

Set out below are some excerpts from the condensed version. The proposal makes some interesting points. I've not read the full law review article. The condensed version does not hone in on two topics that seem key to me: state-by state variations in the applicable legal rules, and the manner in which a jury would cope with the applicable and evolving science in a mass tort "toxic tort" case.

See below for the excerpts that most caught my eye.
___________________________________________________________________


"The reexamination problem reflects tension between competing values in complex litigation: Consolidated cases may lead to unconstitutional reexamination of overlapping issues, yet trying individual cases presents problems of efficiency loss and forum manipulation. We must therefore choose between the evil of bifurcation and the evil of inefficient relitigation of the same issue, with the concomitant risk of inconsistent results. A third option--treating a single litigation as a national unit--vests too much power in one local jury to unleash national consequences.

Is there a fourth option? Empanelling a national jury would mitigate reexamination problems while preserving the efficiency gains of aggregation. A national jury would also address the concern that a local citizenry should not decide issues of national importance. And, most importantly, it would vindicate the animating concern of the Seventh Amendment: citizen participation in civil dispute resolution.

Our willingness to work out the logistical details of the national jury proposal and to absorb its inevitable costs is a function of our commitment to citizen participation in large-scale litigation. One difficulty, of course, will be assembling a national jury pool representative of a country as large and diverse as the United States. Even in much smaller jury districts, underrepresentation of minorities on jury venires has sparked an enormous amount of scholarly literature and litigation.8 Congress would have to consider how to assemble a nationally representative venire. A starting point might be to draw candidates for the national jury pool from congressional districts, since those boundaries have already withstood constitutional and statutory scrutiny under election laws.9 The census process could also be used to draw districts.

The expansion of jury pools from local to national may also require us to rethink the size of the venire and the petit jury, as well as verdict format and voting mechanisms. Obtaining some semblance of the required representativeness will no doubt require larger juries than the current six or twelve members. Indeed, in order for a national jury to function, the discussion may well have to shift to how large a group can effectively deliberate without becoming unwieldy.

The grand jury model may prove useful. One can imagine a national jury as a cross between the grand jury and the special jury: Jurors could serve for specified lengths of time, perhaps in particular courts hosting multi-district complex litigation. The learning curve for such jurors would be high. Having decided, say, causation issues in one products liability case, the national jury would have an informational advantage in understanding procedure and applicable substantive law for other cases. And this gain can be realized without sacrificing the democratic makeup of the jury--a quality lost in elitist special juries.

The civil jury, though steeped in history, is not frozen in time. In an era of increasingly complex litigation, the civil jury must adapt structurally to modern disputes while preserving its rich history and constitutional function. Empanelling national juries in cases of national scope may well be the only way to preserve meaningful citizen participation in large-scale litigation."

Transcript of June 25 GM Hearing on Withdrawal of Request for Asbestos Futures Representative

As a result of bugging the clerk's office and the court reporter's office, the transparency-blocking 90 day veil has now been lifted from some of the General Motors bankruptcy hearing transcripts.

Here is the June 25, 2009 transcript that reflects the asbestos plaintiff's lawyers withdrawing the request for appointment of a futures representative. The withdrawal was based on the grounds that there would not be a section 524(g) injunction order entered in the case and that orders entered in the case do not bind future claimants.

So, the asbestos personal injury litigation saga no doubt will go on as to GM at least for future claims. And, just as the bankruptcy court orders do not bind future personal injury claimants, the orders also should not bind underlying case co-defendants which decide to bring in those cases a contribution or apportionment claim against the new GM entity, if it survives.

Who Will Invest in UK Law Firms When It Becomes Legal in 2011 ?

Law firms as an investment opportunity for non-lawyers? You bet. It is by now well-known that an Australian plaintiff's firm went public back in 2007. This August 3 article from Bloomberg covers the reality that in 2011, it will become legal in the UK for non-lawyers to invest in law firms, and describes several groups that say they are interested in investing in UK law firms.

Lung Cancer Risks Tied to Specific Genome Flaws

Here is an interesting new article that highlights science continuing to evolve as to cancer risks. The conclusion is that the risk of contracting lung cancer is much, much higher for smokers with certain specific genetic variations. The following is the full text of the article:

"Researchers Cough Up New Evidence for Genetic Basis of Lung Cancer Risk in Smokers
GEN News Highlights

Scientists have uncovered new evidence supporting the hypothesis that the genetic background plays a role in determining how likely it is that a smoker will develop lung cancer and what type of cancer it will be. Genome-wide association studies by Cancer Research UK-funded scientists at the Institute of Cancer Research implicated DNA variants within regions on chromosomes 5, 6, and 15.

The work is published in Cancer Research in a paper titled "Deciphering the impact of common genetic variation on lung cancer risk."

The latest ICR work suggests there are two independent sites on chromosome 15 involved in determining lung cancer risk. They calculated that current or former smokers carrying one copy of each of the chromosome 15 variant were at a 28% higher risk of developing lung cancer than smokers without the variants. The relative risk jumped to 80% for either former or current smokers who were homozygous for both chromosome 15 variants. The increased risk of lung cancer was not evident in carriers of the polymorphisms who had never smoked.
Additionally, the sequences on chromosomes 5 and 6 were found to influence the type of lung cancer smokers developed. Individuals who carried the chromosome 5 variation were more likely to develop adenocarcinoma, a type of non-small-cell lung cancer (NSCLC) that represents the most common form of the disease, the ICR researchers point out. The chromosome 6 variant also appeared to influence whether the carrier developed the adenocarcinoma or the squamous cell carcinoma form of NSCLC."

Illegality and In Pari Delicto Defense to Fraud Claims

Barlow Lyde & Gilbert issued this October 7 paper on the "illegality" and "in pari delicto" defenses that auditors and bankers are using to defend themselves against suits by corporate entities that lost monies because of frauds that included the involvement of some personnel of the corporate entities. The paper briefly covers the recent opinion by Judge Kaplan in some of the Parmalat cases and a recent decision from the UK House of Lords.

The outcomes are rather stunning because the result is that an auditor's involvement in massive fraud does not produce an adverse financial outcome for the auditor.

Tags:

New Litigation Investment Fund Expected to Complete IPO in October - Burford Capital, Ltd.

The previously-mentioned London asbestos conference included a presentation regarding a new £200 million litigation investment fund that is to come online this fall through an IPO on AIM. The fund seeks to invest in litigation in the US and elsewhere. The presentation seemed to very much surprise some insurance industry personnel attending the conference. Others said they were not surprised,perhaps because the reality is that some insurers have in the past invested in litigation.

The IPO also was covered briefly by the WSJ in its September 29, 2009 edition. The article is here. It states:



By MARGOT PATRICK LONDON -- Burford Capital Ltd., a closed-end investment company, said it wants to raise up to £200 million ($319 million) in a share placing on London's junior market to mark its place in a small but growing sector of funds that help finance companies' legal costs in commercial disputes.By providing cash to help companies foot their legal costs, Burford said it hopes to pick up a share of any awards or settlements and then pay out money to its shareholders in the form of dividends.

The Guernsey-based company said it will start out by investing in disputes between companies in the U.S., as well as in those going to international arbitration. Later on, it might expand into to other jurisdictions, it said. A typical investment is expected to be for more than $3 million and as high as $15 million.It didn't say what percentage of proceeds it would ask for, but similar funds take between 20% and 45%.

The company's investment adviser is Burford Group Ltd., set up by U.S. lawyers Christoper Bogart and Selvyn Seidel."Third-party commercial-dispute finance is a high-growth market, helping plaintiffs or defendants get civil justice," Mr. Bogart said in a statement. He said these kinds of investment can generate highly attractive returns that aren't tied to the performance of stock markets.

Mr. Bogart's previous jobs include serving as executive vice president and general counsel of Time Warner Inc., and as chief executive of Time Warner Cable Ventures. Mr. Seidel most recently was a senior partner at law firm Latham & Watkins, where he co-founded the New York office and was chairman of the firm's international practice.

Fox-Pitt, Kelton Ltd. is handling the share placement on the Alternative Investment Market and will be the company's nominated adviser and broker. Execution Ltd. is acting as co-lead manager on the placement. The shares are expected to start trading around Oct. 16.

A similar company called Juridica Investments Ltd. listed its shares on AIM in December 2007, raising £80 million.

Write to Margot Patrick at margot.patrick@dowjones.com

Caveat/Disclosure: As a result of this prior post on May 24, 2009, I ended up receiving a call from Mr. Seidel to talk about the topic of litigation funding. As indicated in the prior post, it seems plain to me that litigation funding will become a dominant agent for change in litigation over the next decade. So, I invested the time to meet with Mr. Seidel a couple of times. The plans of Mr. Seidel and his colleagues make great sense to me, and I hope to work with them some day if the situation is right.

Green House Gas Ruling and More Regulations Ahead

The focus on greenhouse gases continues to increase. As I prepared to leave the country, the 2d Circuit issued its opinion allowing a greenhouse gas claim based on nuisance. The opinion is here.
In addition, environmental regulation of greenhouse gas reporting also is increasing. The Marten Group's always helpful website describes two new sets of proposed GHG regulations; one set from the U.S. EPA and one set from the State of Washington. The firm and Environ also are offering a free seminar on the topics - look for information in the upper right hand corner of the home page.

Contingency Fees in Europe - Spain's Supreme Court Allows Contingency Fees and Thus Increases the Pressures on Other Nations

I'm back to work after enjoying about 10 days of travel in Europe. Each day of the trip revolved around law in one way or the other and provided some great opportinuties for learning It was great to meet new people and exchange ideas and information about legal systems and law around the world. On and off over the next couple of weeks, some posts here will provide brief comments on some of the exchanges relevant to tort litigation. If interested, read after the line below for more specifics on reasons for the trip and the resulting learning opportunities.

One new piece of knowledge gained is that Spain's Supreme Court ruled last November that contingency fees can not be prohibited and so are now legal in Spain. This news was provided by Albert Azagra Malo, a Spanish law school instructor who has written extensively on mass tort issues and this year was in Chicago to obtain an LLM from the University of Chicago. Albert is a great person and quite learned - you can find him here on LinkedIn.

Overall, the ruling in Spain makes the point that it's time to forget the old bromide that Europe will never allow contingent fees. UK countries and others already allow "uplift" fees that provide a modest fee through a fee multiplier, and the countries are are under increasing pressures to embrace pure contingency fees. Indeed, I spoke with an excellent UK defense lawyer who said he expects to see contngency fees adopted in the UK within the next few years. The ruling in Spain adds to the pressures because the gist of the ruling is that prohibiting contingency fees unduly restricts competition and imposes a minimum fee requirement. Here is a paper - in Spanish - that provides more specifics on the opinion. The SSRN abstract for the paper calls the ruling a revolutionary decision and explains the ruling as follows:

"Contingent fees have been traditionally prohibited in the Spanish legal system. However, on November 4th, 2008, the Spanish Supreme Court rendered a revolutionary decision on the issue. Under Competition Law, the Court quashed the prohibition under the reasoning that it affected competition by restricting the attorney and its client to freely set the price of the legal assistance and, therefore, imposing indirectly a minimum fee."

___________________________________________________________________

Among other things, two organized events provided opportunities for learning. One event was an asbestos litigation conference I chaired in London on asbestos claiming around the globe. The conference was attended by lawyers from Australia, UK, Switzerland, Germany, Italy, Spain and France. We made the conference quite interactive and so everyone learned even more.

The second opportunity for learning was a meeting of 99 lawyers from 49 countries for the annual meeting of international law group known as the International Business Law Consortium. The IBLC provides global contacts and resources for medium and small law firms around the world. My law firm has been a member for about 4 years and the meetings, calls and emails offer a great way to meet excellent lawyers and learn more about what's happening in the real world. We also seek to refer work to each other, and thus last month I spent some time working with a lawyer in the Netherlands on trademark issues.